blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1317270

EP1317270 - EXEMESTANE FOR THE TREATMENT OF OESTROGEN-DEPENDENT CANCERS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  23.07.2010
Database last updated on 12.11.2024
Most recent event   Tooltip23.07.2010Application deemed to be withdrawnpublished on 25.08.2010  [2010/34]
Applicant(s)For all designated states
Pfizer Italia S.r.l.
Strada Statale 156 Km. 50
04010 Latina / IT
For all designated states
Pharmacia & Upjohn Company LLC
7000 Portage Road
Kalamazoo, MI 49001 / US
[2007/04]
Former [2006/31]For all designated states
Pfizer Italia S.r.l.
Strada Statale 156 Km. 50
04010 Latina / IT
For all designated states
Pharmacia & Upjohn Company LLC
301 Henrietta Street
Kalamazoo, MI 49001 / US
Former [2005/22]For all designated states
Pharmacia Italia S.p.A.
Via Robert Koch 1.2
20152 Milano / IT
For all designated states
Pharmacia & Upjohn Company LLC
301 Henrietta Street
Kalamazoo, MI 49001 / US
Former [2003/24]For all designated states
Pharmacia Italia S.p.A.
Via Robert Koch 1.2
20152 Milano / IT
For all designated states
Pharmacia & Upjohn Company
301 Henrietta Street
Kalamazoo, MI 49007 / US
Inventor(s)01 / DI SALLE, Enrico
Viale Andrea Doria, 5
I-20124 Milano / IT
02 / PISCITELLI, Gabriella
Via Piacenza, 13
I-20135 Milano / IT
03 / MASSIMINI, Giorgio
Via Padre Carlo Vigevano, 26
I-20081 Abbiategrasso / IT
04 / PURANDARE, Dinesh
6 Macintosh Road
Branchburg, NJ 08876 / US
05 / MARTINI, Alessandro
Via Desiderio da Settignano, 14
I-20149 Milano / IT
06 / MUGGETTI, Lorena
Via Trento, 38
I-20036 Meda / IT
 [2003/24]
Representative(s)Modiano, Micaela Nadia, et al
Modiano Josif Pisanty & Staub Ltd
Thierschstrasse 11
80538 München / DE
[N/P]
Former [2009/36]Modiano, Micaela Nadia, et al
Modiano Josif Pisanty & Staub Ltd Thierschstrasse 11
80538 München / DE
Former [2004/35]Modiano, Micaela Nadia, et al
Modiano, Josif, Pisanty & Staub, Baaderstrasse 3
80469 München / DE
Former [2003/24]Longoni, Alessandra
Pharmacia Italia S.p.A., Patent Department, Viale Pasteur 10
20014 Nerviano (MI) / IT
Application number, filing date01969689.731.08.2001
[2003/24]
WO2001EP10172
Priority number, dateUS2000065805208.09.2000         Original published format: US 658052
[2003/24]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO0220020
Date:14.03.2002
Language:EN
[2002/11]
Type: A1 Application with search report 
No.:EP1317270
Date:11.06.2003
Language:EN
The application published by WIPO in one of the EPO official languages on 14.03.2002 takes the place of the publication of the European patent application.
[2003/24]
Search report(s)International search report - published on:EP14.03.2002
ClassificationIPC:A61K31/5685, A61P35/00
[2003/24]
CPC:
A61K45/06 (EP,US); A61K31/5685 (EP,KR,US); A61P35/00 (EP);
A61P43/00 (EP); A61P5/32 (EP)
C-Set:
A61K31/5685, A61K2300/00 (EP,US)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2003/24]
Extension statesAL07.04.2003
LT07.04.2003
LV07.04.2003
MK07.04.2003
RO07.04.2003
SI07.04.2003
TitleGerman:EXEMESTAN ZUR BEHANDLUNG VON AUF ÖSTROGEN ABHÄNGIGEN KREBS[2003/24]
English:EXEMESTANE FOR THE TREATMENT OF OESTROGEN-DEPENDENT CANCERS[2003/24]
French:UTILISATION D'EXEMESTANE COMME AGENT DE CHIMIO-PREVENTION[2003/24]
Entry into regional phase07.04.2003National basic fee paid 
07.04.2003Designation fee(s) paid 
07.04.2003Examination fee paid 
Examination procedure22.03.2002Request for preliminary examination filed
International Preliminary Examining Authority: EP
07.04.2003Examination requested  [2003/24]
22.05.2003Amendment by applicant (claims and/or description)
07.10.2005Despatch of a communication from the examining division (Time limit: M06)
01.08.2006Reply to a communication from the examining division
02.07.2007Despatch of a communication from the examining division (Time limit: M06)
20.03.2008Reply to a communication from the examining division
02.03.2010Application deemed to be withdrawn, date of legal effect  [2010/34]
08.04.2010Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2010/34]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
20.03.2008Request for further processing filed
20.03.2008Full payment received (date of receipt of payment)
Request granted
08.04.2008Decision despatched
25.07.2006Request for further processing filed
25.07.2006Full payment received (date of receipt of payment)
Request granted
08.08.2006Decision despatched
Fees paidRenewal fee
06.08.2003Renewal fee patent year 03
06.08.2004Renewal fee patent year 04
08.08.2005Renewal fee patent year 05
07.08.2006Renewal fee patent year 06
03.08.2007Renewal fee patent year 07
08.08.2008Renewal fee patent year 08
Penalty fee
Additional fee for renewal fee
31.08.200909   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[DX]US4808616  (BUZZETTI FRANCO [IT], et al) [DX] 4,5 * abstract * * column 1, line 5 - line 16 * * examples 8,9 * * claims 1-7 *;
 [X]WO0037107  (SEARLE & CO [US], et al) [X] 4,5 * abstract * * page 141, line 22 * * claims 1,58,115,142,145 *;
 [X]WO9729735  (UNIV MONASH [AU], et al) [X] 4,5 * abstract * * page 26, line 5 * * claims 23,30 *;
 [EL]WO0164193  (PHARMACIA & UPJOHN SPA [IT], et al) [EL] 4,5 * abstract * * page 1, line 5 - page 2, line 24 * * page 4, line 9 - line 17 * * page 5, line 3 - line 13 * * claims 1-17 * * L: Priority *;
 [PXL]WO0069467  (PHARMACIA & UPJOHN SPA [IT], et al) [PXL] 4,5 * abstract * * page 1, line 5 - line 9 * * page 4, line 22 - page 7, line 13 * * L: Priority *
 [X]  - LONNING, P.E. ET AL., "Activity of exemestane in metastatic breast cancer after failure of non-steroidal aromatase inhibitors: a phase II trial", JOURNAL OF CLINICAL ONCOLOGY, (200006), vol. 18, no. 11, pages 2234 - 2244, XP001034132 [X] 4,5 * abstract *
 [X]  - BUZZETTI, F; DI SALLE, E; LONGO, A; BRIATICO, G, ""Synthesis and aromatase inhibition by potential metabolites of exemestane (6-methylenandrosta-1,4-diene-3,17-dione", STEROIDS, (1993), vol. 58, no. 11, pages 527 - 532, XP001037784 [X] 4,5 * abstract * * introduction *

DOI:   http://dx.doi.org/10.1016/0039-128X(93)90029-M
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.